This project proposes the preparation and preliminary studies of selenazoidine carboxylic acids as novel selenium delivery agents. Selenium is of growing importance in human health beyond its well-recognized role as a micronutrient. For example, selenium has exhibited exciting activity as a cancer chemopreventive agent against disease in several organs, caused by a variety of carcinogens. Selenium is also known for its toxicity, however, making the development of clinically valuable agents a distinct challenge that must be accomplished with extreme care and creativity. The selenocysteine and were designed to provide a continuous supply of the amino acid over time at levels high and sustained enough to have therapeutic value but not high enough to produce toxicity. The current application will accomplish two specific aims: (1) synthesizing two prototype selenazolidine prodrugs; and (2) conducting pilot studies in a mouse model to explore: (a) the toxicity of the novel agents; (b) their effect on the selenium content in blood and tissue; (c) their ability to provide biologically available selenium as measured by increased activity of the selenium-dependent enzyme, glutathione peroxidase; and (d) their ability to function as chemopreventive agents against nitrosamine-induced lung cancer. These analogs are completely novel. It appears to be an entirely new approach in the selenium field and may allow the potential of selenium as a preventive and/or therapeutic agent in human disease to be clinically realized.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM058913-02
Application #
6386401
Study Section
Nutrition Study Section (NTN)
Program Officer
Okita, Richard T
Project Start
2000-06-01
Project End
2003-05-31
Budget Start
2001-06-01
Budget End
2003-05-31
Support Year
2
Fiscal Year
2001
Total Cost
$112,469
Indirect Cost
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Poerschke, Robyn L; Franklin, Michael R; Bild, Andrea H et al. (2012) Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. J Biochem Mol Toxicol 26:344-53
Poerschke, Robyn L; Franklin, Michael R; Moos, Philip J (2008) Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid. Toxicol In Vitro 22:1761-7
Franklin, Michael R; Moos, Philip J; El-Sayed, Wael M et al. (2007) Pre- and post-initiation chemoprevention activity of 2-alkyl/aryl selenazolidine-4(R)-carboxylic acids against tobacco-derived nitrosamine (NNK)-induced lung tumors in the A/J mouse. Chem Biol Interact 168:211-20
El-Sayed, Wael M; Hussin, Warda A; Franklin, Michael R (2007) The antimutagenicity of 2-substituted selenazolidine-4-(R)-carboxylic acids. Mutat Res 627:136-45
El-Sayed, Wael M; Aboul-Fadl, Tarek; Roberts, Jeanette C et al. (2007) Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds. Toxicol In Vitro 21:157-64
El-Sayed, Wael M; Franklin, Michael R (2006) Hepatic chemoprotective enzyme responses to 2-substituted selenazolidine-4(R)-carboxylic acids. J Biochem Mol Toxicol 20:292-301
Li, Liang; Xie, Yang; El-Sayed, Wael M et al. (2005) Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J Biochem Mol Toxicol 19:396-405
Li, Liang; Xie, Yang; El-Sayed, Wael M et al. (2004) Characteristics of selenazolidine prodrugs of selenocysteine: toxicity, selenium levels, and glutathione peroxidase induction in A/J mice. Life Sci 75:447-59
Short, Megan D; Xie, Yang; Li, Liang et al. (2003) Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells. J Med Chem 46:3308-13
Dominick, P K; Cassidy, P B; Roberts, J C (2001) A new and versatile method for determination of thiolamines of biological importance. J Chromatogr B Biomed Sci Appl 761:1-12